Seres Therapeutics Inc
MCRB
Market Cap$103.65M
Close$
$-7.83
166% downside
Current Fair Value
166% downsideOvervalued by 166% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $103.65 Million |
|---|---|
| Enterprise Value | $136.52 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $0 |
| Beta | 2.62 |
| Outstanding Shares | 8,703,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 1.42 |
|---|---|
| PEG | -0.78 |
| Price to Sales | - |
| Price to Book Ratio | 2.37 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.29 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | 0.67 |
| Debt to Equity | 1.82 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Seres Therapeutics Inc
CEO: Eric Shaff